VAERS 2021 Database www.vaers.hhs.gov

Main Page | All 2021 Deaths | Videos
VAERS Updated: 10/01/2021
** VAERS DATABASE Last updated: October 1, 2021**
PLEASE CHECK BACK SOON
Download the files above while you wait.






Manufacturers

Total Manufacturer
187,133MODERNA
33,878JANSSEN
2,321PFIZER\BIONTECH
1,091GLAXOSMITHKLINE BIOLOGICALS
983UNKNOWN MANUFACTURER
363MERCK & CO. INC.
229SEQIRUS, INC.
45DYNAVAX TECHNOLOGIES CORPORATION
41NOVARTIS VACCINES AND DIAGNOSTICS
29SANOFI PASTEUR
18EMERGENT BIOSOLUTIONS
8PAXVAX
7TEVA PHARMACEUTICALS
4PFIZER\WYETH
3BERNA BIOTECH, LTD.
2SMITHKLINE BEECHAM
2INTERCELL AG
2PROTEIN SCIENCES CORPORATION
1CSL LIMITED

Incidents per State

State Total
77,548
AK1,869
AL5,581
AR3,688
AS47
AZ14,288
CA61,984
CO11,665
CT8,149
DC1,663
DE1,807
FL37,749
FM5
GA15,058
GU120
HI2,453
IA4,625
ID2,692
IL20,334
IN24,007
KS4,615
KY7,696
LA4,887
MA14,654
MD12,514
ME3,129
MH11
MI18,739
MN12,528
MO9,710
MP29
MS2,790
MT2,375
NC16,368
ND1,356
NE2,880
NH3,100
NJ17,634
NM3,916
NV4,239
NY34,355
OH19,081
OK6,195
OR8,636
PA23,083
PR2,370
QM2
RI2,088
SC6,411
SD1,212
TN9,131
TX35,174
UT4,273
VA14,937
VI64
VT1,676
WA14,909
WI11,259
WV2,388
WY861
XB5
XL1
XV2

ID: 1426606
Sex: F
Age:
State: PA

Vax Date: 02/15/2021
Onset Date: 02/16/2021
Rec V Date: 06/25/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 037K20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Dysphagia, Epiglottitis

Symptoms: shingles on chest back and right ear; feverish; body aches; fatigue; This is a spontaneous report from a contactable other healthcare professional. A 41-Year-old non pregnant female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; lot number: EN6201), via unspecified route of administration in left arm on 15Feb2021 at 04:45 pm (at the age of 41-years-old) as a single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient has not had symptoms associated with COVID-19. Patient had not tested positive for COVID-19 since having the vaccine. No known allergies to medications, food, or other products. On 16Feb2021, the day after vaccine, the patient experienced feverish, body aches and fatigue. On 04Mar2021, two weeks after the shot the patient ended up with shingles on chest back and in right ear. Treatment (unspecified) for shingles was ongoing and one ER visit for doctor. Therapeutic measures were taken for the event shingles. The clinical outcome of the events feverish, body aches, fatigue and shingles were not recovered. No follow-up attempts are possible. No further information is expected.

Other Meds:

Current Illness:

ID: 1426607
Sex: F
Age:
State: OH

Vax Date: 03/17/2021
Onset Date: 03/18/2021
Rec V Date: 06/25/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025L20A
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Anxiety, Dyspnoea

Symptoms: Really bad cluster headache on righthand side of head; High blood pressure; Racing pulse rate; Fever; Chills; This is a spontaneous report from a contactable consumer, the patient. A 43-year-old non-pregnant female patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EN6205) via an unspecified route of administration in the left arm on 17Mar2021 at 11:30 (at the age of 43-years-old) as a single dose for COVID-19 immunisation. Medical history was not reported. Concomitant medications included pantoprazole (MANUFACTURER UNKNOWN), bromocriptine (MANUFACTURER UNKNOWN), simvastatin (MANUFACTURER UNKNOWN) and amitriptyline (MANUFACTURER UNKNOWN) for an unknown indication from an unknown date. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EN6198), via an unspecified route of administration in the left arm on 24Feb2021 at 15:30 (at the age of 43-years-old) as a single dose for COVID-19 immunisation. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient was not diagnosed with COVID -19 prior to vaccination and since the vaccination, the patient had not been tested for COVID -19. On 18Mar2021 at 02:00, the patient experienced really bad cluster headache on right hand side of head, fever, chills, high blood pressure and racing pulse rate. The patient did not receive any treatment for reported events. The clinical outcome of the events really bad cluster headache on right hand side of head, fever, chills, high blood pressure and racing pulse rate were not recovered at the time of reporting. No follow-up attempts are needed. No further information is expected.

Other Meds: BROMOCRIPTINE; AMITRIPTYLINE; PANTOPRAZOLE; SIMVASTATIN

Current Illness:

ID: 1426608
Sex: M
Age:
State: CA

Vax Date: 03/17/2021
Onset Date: 03/18/2021
Rec V Date: 06/25/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot: EL1284
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Chest discomfort, Dysphagia, Pain in extremity, Visual impairment

Symptoms: itchy rash; Redness on my face; This is a spontaneous report received from a contactable consumer, the patient. A 65-year-old male patient received unknown single dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot no: Ep6955) via unspecified route of administration on the left arm on 17Mar2021 at 15:15, for COVID-19 immunisation. No medical history and the patient concomitant medications were not reported and he had no known allergies. Prior to vaccination, patient was not diagnosed with COVID-19 and since the vaccination the patient was not tested for COVID-19. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. On 18Mar2021, at 12:30 the patient had itchy rash on the wrist about 30 hours after the vaccination, the rash spread overnight and itching felt worst and also the patient developed redness on the face. Treatment medications for the events included the use of BENADRYL. Also, it was reported that the redness on face improved after taking half a pill of Benadryl. The clinical outcome of itchy rash was not recovered and redness in the face was recovering at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1426609
Sex: F
Age:
State: FL

Vax Date: 03/12/2021
Onset Date: 03/14/2021
Rec V Date: 06/25/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: unknown
Dose Series: UNK
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Dizziness, Fatigue, Mobility decreased

Symptoms: Swollen lymph nodes under left armpit; Painful lymph nodes under left armpit; This is a spontaneous report received from a contactable consumer, the patient. A 32-year-old non pregnant female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: En6208) via an unspecified route of administration in the left arm on 12Mar2021 at 14:45 (at the age of 32-year-old), as single dose for COVID-19 immunisation. The patients medical history included fibromyalgia and penicillin allergy. The patients past drug history included penicillin (MANUFACTURER UNKNOWN) for unspecified indication. Concomitant medication included pantoprazole (MANUFACTURER UNKNOWN) for an unspecified indication and from an unknown date. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 14Mar2021, the patient had swollen and painful lymph nodes under left armpit. The clinical outcome of the events Painful lymph nodes under left armpit and swollen lymph nodes under left armpit was not resolved at the time of this report. No follow-up attempts are possible. No further information is expected.

Other Meds: PANTOPRAZOLE

Current Illness:

ID: 1426610
Sex: F
Age:
State: WI

Vax Date: 03/19/2021
Onset Date: 03/19/2021
Rec V Date: 06/25/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site erythema, Injection site pruritus, Injection site swelling, Injection site warmth

Symptoms: Inadvertant administration of > thanrecommended dose. Vial was notreconstituted with diluent and patientreceived 0.3ml of undiluted vaccine; Inadvertant administration of greater than recommended dose.; This is a spontaneous report from a contactable pharmacist, the patient. A 36-year-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EN6207) via an intramuscular route of administration on left arm on 19Mar2021 at 9:30 (at the age of 36-years-old) as a single dose for COVID-19 immunisation. Medical history not reported. The patients allergies to medications, food, or other products were NKDA. The patient did not receive any other vaccines within four weeks prior to the vaccination. It was unknown if the patient was pregnant. It was unknown if the patient was diagnosed with COVID-19 prior to vaccination. It was unknown if the patient has tested for COVID-19 since the vaccination. Concomitant medication not reported. On 09Mar2021 at 9:30 the patient had inadvertant administration of greater than recommended dose, vial was not reconstituted with diluent and the patient received 0.3ml of undiluted vaccine. The clinical outcome for the event inadvertant administration of greater than recommended dose, vial was not reconstituted with diluent and patient received 0.3ml of undiluted vaccine was unknown. No follow-up attempts are possible. No further information is expected.

Other Meds:

Current Illness:

ID: 1426611
Sex: F
Age:
State: PA

Vax Date: 03/16/2021
Onset Date: 03/17/2021
Rec V Date: 06/25/2021
Hospital:

Vax Type: FLUC4
Manufacturer: SEQIRUS, INC.
Vax Name: INFLUENZA (SEASONAL) (FLUCELVAX QUADRIVALENT)
Lot: 276563
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Chills, Confusional state, Eye inflammation, Headache, Laboratory test

Symptoms: extremely fatigued; slight chills; slight nausea; This is a spontaneous report received from a contactable patient. A 75-years-old non-pregnant female patient received her second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EP7534 via an unspecified route of administration in left arm at 11:45 on 16Mar2021, at the age of 75 years as a single dose, for COVID-19 immunisation. Medical history was not reported. The patient did not have any allergies to food, medications, or other products. Prior to the vaccination the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested positive for COVID-19. Concomitant medications included fish oil (MANUFACTURER UNKNOWN) on unspecified dates taken for unspecified indication, magnesium (MANUFACTURER UNKNOWN) on unspecified dates taken for unspecified indication, glucosamine (MANUFACTURER UNKNOWN) on unspecified dates taken for unspecified indication and biotin (MANUFACTURER UNKNOWN) on unspecified dates taken for unspecified indication. The patient previously took first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EL9269 via an unspecified route of administration in left arm at 16:00 on 22Feb2021, as a single dose, for COVID-19 immunisation. After receiving second dose, patient experienced extremely fatigue, slight chills and slight nausea at 19:00 on 17Mar2021. The patient did not receive any treatment for events. Facility where the most recent COVID-19 vaccine was administered: Other. The clinical outcome of events extremely fatigued, slight chills and slight nausea was recovered on an unspecified date at the time of reporting. No follow up required. No further information expected.

Other Meds: FISH OIL; GLUCOSAMINE; BIOTIN; MAGNESIUM

Current Illness:

ID: 1426612
Sex: F
Age:
State: NY

Vax Date: 03/08/2021
Onset Date: 03/08/2021
Rec V Date: 06/25/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Pyrexia, White blood cell count decreased

Symptoms: Dizziness; Injection site pain; Fatigue; This is a spontaneous report received from a contactable consumer, the patient. A 37-years-old non-pregnant female patient received her first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: UNKNOWN] via an unspecified route of administration in left arm on 08Mar2021, at 14:30(at the age of 37-year-old) as a single dose, for COVID-19 immunisation. Medical history included asthma. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested positive for COVID-19. Concomitant medications included buspirone (MANUFACTURER UNKNOWN), SYNTHROID and WELLBUTRIN. The patient experienced dizziness, vaccination site pain and fatigue on 08Mar2021, at 16:00. No therapeutic measures were taken for the reported events. The clinical outcome of events vaccination site pain, fatigue and dizziness was recovered on unknown date in Mar2021. Information about lot number cannot be obtained. No further information expected.

Other Meds: WELLBUTRIN; SYNTHROID; BUSPIRONE

Current Illness:

ID: 1426613
Sex: M
Age:
State: TX

Vax Date: 03/16/2021
Onset Date: 03/16/2021
Rec V Date: 06/25/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: UNK
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Pharyngeal swelling

Symptoms: Confusion; Severe stomach pain; Balance; Body aches; severe vomiting/ puking; Temperature 100.3; Diarrhea; Fatigue; Arm ache; Severe nausea; This is a spontaneous report from a contactable consumer, the patient. A 74-year-old, male patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot number: En6204) via an unspecified route of administration in the left arm on 16Mar2021 at 13:00 (at the age of 74-years-old), as a single dose for COVID-19 immunisation. The patient medical history included Diabetes, emphysema, HTN, COPD, and COVID-19 on an unspecified date in Nov2020. Concomitant medications were not reported. The patient did not have allergies to food, medication and other products. The patient did not receive any other vaccines within 4 weeks prior to the COVID-19 vaccine. Prior to vaccination the patient was tested positive for COVID-19 in Nov2020. Since the vaccination, the patient has not been tested for COVID-19. On 16Mar2021, at 1700, the patient experienced events, severe nausea, vomiting, puking, temperature 100.3(Units unspecified), arm ache, body aches, fatigue, severe stomach pain and diarrhea, balance, and confusion, The patient did not receive any treatment as a result of adverse events. The events didn't result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care'. The clinical outcome of the events nausea, vomiting, fatigue, loss of balance, confusion, pain in arm, generalized body pains, stomach pain, diarrhea, and increase body temperature was recovered with sequelae. No follow-up attempts are possible; No further information is expected

Other Meds:

Current Illness:

ID: 1426614
Sex: F
Age:
State: OH

Vax Date: 03/18/2021
Onset Date: 03/18/2021
Rec V Date: 06/25/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Abdominal pain, Chills, Sleep disorder

Symptoms: Sore arm; chills; tiredness; swollen lymph node; This is a spontaneous report from a contactable consumer, the patient. A 34-year-old non-pregnant female patient received second dose of BNT162B2 (PFIZER BIONTECH COVID-19 mRNA COVID-19 VACCINE; Lot number: EN6206), via an unspecified route of administration in her left arm on 18Mar2021 at 17:00 hours (at the age of 34-years-old), as a single dose for COVID-19 immunisation. Medical history included Obstructive Sleep Apnea (OSA), pre-diabetic, obesity, non-alcoholic fatty liver disease and gastroparesis. No concomitant medications were not reported within two weeks of vaccination. The patient had previously received first dose of BNT162B2 (PFIZER BIONTECH COVID-19 mRNA COVID-19 VACCINE; Lot number: EN6202), via an unspecified route of administration in her left arm on 25Feb2021 at 17:00 hours, as a single dose for COVID-19 immunisation. The patient did not receive any other vaccine within 4 weeks prior to COVID-19 vaccine. The patient was not diagnosed with COVID-19 prior to vaccination and the patient has not tested positive for COVID-19 since receiving the vaccine. On 18Mar2021, the patient experienced sore arm, chills, tiredness, and swollen lymph node. No therapeutic measures were taken as a result of the events experienced. The clinical outcome of the events sore arm, chills, tiredness and swollen lymph node was recovering at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1426615
Sex: M
Age:
State: IL

Vax Date: 03/14/2021
Onset Date: 03/15/2021
Rec V Date: 06/25/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011J201A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Diarrhoea, Nasal congestion

Symptoms: Swollen lymph node in underarm area; This is a spontaneous report from a contactable consumer, the patient. A 34-years-old-male patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: Unknown,) via an unspecified route of administration in left arm on 14Mar2021 at 12:45 (at the age of 34-years-old) as a single dose for COVID-19 immunisation. The patient had no medical history and concomitant medications. The patient had no allergy to medications, food, or other products. The patient had not received any vaccine within four weeks prior to the COVID-19 vaccine. Prior to vaccination and since the vaccination the patient had not been diagnosed with COVID-19. On 15Mar2021 at 18:00, the patient experienced swollen lymph node in underarm area. The patient had not received any therapeutic measure or treatment taken for the resulted adverse event. The clinical outcome of swollen lymph node was resolving. Information about lot/batch number cannot be obtained. No further information is expected.

Other Meds:

Current Illness:

ID: 1426616
Sex: F
Age:
State: FL

Vax Date: 03/15/2021
Onset Date: 03/15/2021
Rec V Date: 06/25/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Vaccination site erythema, Vaccination site pruritus, Vaccination site swelling

Symptoms: Soreness at the injection site; Mild itchy tingling type sensation and a mild pins and needles sensation all over her body; Mild itchy tingling type sensation and a mild pins and needles sensation all over her body; This is a spontaneous report from a contactable other hcp. (patient). A 47-years-old female patient received bnt162b2 (BNT162B2, Solution for injection), dose 1 via an unspecified route of administration, administered in Deltoid Right on 15Mar2021 15:58 (at the age of 47-years-old) (Batch/Lot Number: EN6206) as DOSE 1, SINGLE for covid-19 immunisation. Medical history included ear disorder from 03Feb2021 to an unknown date. Caller stated this is all COVID issue post COVID. Caller stated this ended within the last maybe week or so. Concomitant medication(s) included omeprazole (OMEPRAZOLE) taken for gastrooesophageal reflux disease, start and stop date were not reported. The patient previously took a medication which was a steroid called Methylprednisolone for her ear problems that she ended up discontinuing because she had an adverse effect to the medication, so she discontinued it on 15Feb2021. Prior Vaccinations (within 4 weeks) and AE(s) following prior vaccinations details was reported as none. Caller stated she received the vaccine on Monday 15Mar2021 at 15:58 HR and three hours later noticed a pen and needle itchy sensation all over the body and it is mild not severe. Caller stated it was noticeable of course more like annoyance right now. Caller stated the other symptom was soreness at the injection site (on 15Mar2021 20:00). For pen and needle itchy sensation all over the body the as time went on and the following day it was a moderate type soreness then started declining so it is improving. Caller stated she was still feeling a little soreness, but it was improving. Called stated she was not certain of the seriousness criteria of the pen and needle itchy sensation all over the body. Caller stated she knew it was not feeling tingly and the pen needle feelings she did not feel before but now she was felling that sensation and she was not sure if it was connected. AE(s) did not require a visit to emergency room or physician office. Caller stated she tried antihistamine Benadryl (25mg) lot numbers: 1761324, expiration Mar2022, did not really, maybe a minor difference, but sensation is still there so not resolving. The outcome of the events mild itchy tingling type sensation and a mild pins and needles sensation all over her body was not recovered and outcome for soreness at the injection site was recovering. Information on Lot/Batch number was available. Additional information has been requested.

Other Meds: OMEPRAZOLE

Current Illness:

ID: 1426617
Sex: F
Age:
State: AL

Vax Date: 03/16/2021
Onset Date: 03/16/2021
Rec V Date: 06/25/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 039k20a
Dose Series: 1
Vax Route: SYR
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Rash, Urticaria

Symptoms: This is a spontaneous report received from a contactable consumer, the patient. A 43-year-old non-pregnant female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: Unknown) via an unspecified route of administration in her left arm on 16Mar2021 at 13:30(at the age of 43-years-old), as a single dose for COVID-19 immunization. The patient medical history included diabetic and latex allergy. The patient past drug history included lisinopril (MANUFACTURER UNKNOWN). Concomitant medications included januvia, metoprolol (MANUFACTURER UNKNOWN), glipizide (MANUFACTURER UNKNOWN) and sertraline (MANUFACTURER UNKNOWN) received within 2 weeks of vaccination. The patient had not received any other vaccines within 4 weeks prior to the COVID-19 vaccine. Prior to the vaccination, the patient had diagnosed with COVID-19. Since the vaccination patient had not been tested for COVID-19. The patient was allergic to latex and lisinopril. On 16Mar2021 at 15:30, the patient was ill for 2 full days, fever, nausea, chills, body aches and headache. The patient did not receive treatment for the reported events. The clinical outcome for illness, fever, nausea, chills, body aches, headache was recovered at the time of this report. Information about lot/batch number cannot be obtained. No further information is expected.

Other Meds: GLIPIZIDE; Januvia; METOPROLOL; SERTRALINE

Current Illness:

ID: 1426618
Sex: F
Age:
State: CO

Vax Date: 03/04/2021
Onset Date: 03/04/2021
Rec V Date: 06/25/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Blood pressure decreased, Chest pain, Chills, Confusional state, Decreased appetite

Symptoms: Mild soreness at site of injection; This is a spontaneous report received from a contactable healthcare professional, the patient. A 43-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EL3248) via an unspecified route of administration in the left arm on 04Mar2021 at 10:30 (at the age of 43-year-old) as a single dose, for COVID-19 immunisation. Medical history included hypothyroid and anemia. Concomitant medications included levothyroxine (MANUFACTURER UNKNOWN) with a dose of 112 microgram, orally once a day and multivitamin. No known allergies were reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not tested positive for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccine. On 04Mar2021 at 17:30, the patient experienced mild soreness at site of injection. The patient did not receive any treatment for the adverse event. The adverse event did not result in a visit to the doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the event mild soreness at site of injection was recovered on an unspecified date in Mar2021. No follow-up attempts are needed. No further information is expected.

Other Meds: LEVOTHYROXIN

Current Illness:

ID: 1426619
Sex: F
Age:
State:

Vax Date: 03/16/2021
Onset Date: 03/16/2021
Rec V Date: 06/25/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025J20-2A
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Dyspnoea, Fatigue, Feeling abnormal, Head discomfort, Headache

Symptoms: Headache; This is a spontaneous report from non-contactable other healthcare professional. A 70-year-old female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6205), via an unspecified route of administration in the left deltoid muscle on 16Mar2021 (at the age of 70-year-old), as single dose for COVID-19 immunisation. Medical history included previous reactions of anaphylaxis to an unspecified eye gtt as a teenager. Concomitant medications were not reported. On 16May2021, the patient experienced headache during her 30-minute waiting period after the injection. Therapeutic measures were taken as a result of headache and included treatment with Tylenol, observation and snacks. The follow up response to treatment was excellent and the patient was stable to go home and follow up with PCP. The clinical outcome of headache was unknown. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1426620
Sex: M
Age:
State: TN

Vax Date: 03/03/2021
Onset Date: 03/11/2021
Rec V Date: 06/25/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Heart rate decreased, Heart rate increased, Hypertension, Injection site pain, Musculoskeletal chest pain

Symptoms: eight days after my first vaccine, I had a routine blood test and the results of my platelet count was 111.; This is a spontaneous report from a contactable consumer, the patient. A 69-year-old male patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA vaccine; Lot number: unknown), via an unspecified route of administration in the left arm on 03Mar2021 at 10:45 (at the age of 69 years old) as a single dose for COVID-19 immunisation. Medical history included high cholesterol, high blood pressure, seasonal allergies, obstructive sleep apnea, and kidney stones. Concomitant medications included prescribed medications and two over the counter medications which are unspecified. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient was not tested for COVID-19. It was reported that he had been reading about the possibility of low platelet counts due to the vaccine. On 23Jun2020 his platelet count was 130, on the low normal range. On 11Mar2021, eight days after his first vaccine, he had a routine blood test and the results of his platelet count was 111 (low platelet count). The patient doubted if it had any correlation. The patient did not receive treatment for the event. The clinical outcome of abnormal platelet count was unknown. Information about lot number cannot be obtained. No further information is expected.

Other Meds:

Current Illness:

ID: 1426621
Sex: M
Age:
State: TX

Vax Date: 03/18/2021
Onset Date: 03/19/2021
Rec V Date: 06/25/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Nausea, Pain, Pain in extremity, Paraesthesia oral, Pyrexia

Symptoms: 100.4 Degree temperature; Chills; This is a spontaneous report from a contactable consumer, the patient. A 63-year-old male patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; batch number: ER8727) in the left arm on 18Mar2021 at 11:30 hours (at the age 60-year-old) as a single dose for COVID-19 immunisation. The medical history was not reported. The patient had allergies to pollen in the air. Concomitant medications included vitamin-c (MANUFACTURE UNKNOWN), multi-vitamin (MANUFACTURE UNKNOWN) and ther-biotic complete (MANUFACTURE UNKNOWN). The patient underwent lab tests which included nasal swab test on 05Oct2020 and had tested negative. The patient had not received any other vaccines within 4 weeks prior to the COVID-19 vaccine. The patient was not diagnosed with COVID-19 prior to vaccination. Since the vaccination, (on an unknown date) the patient had taken a COVID-19 test. On 19Mar2021 at 01:30 hours, the patient experienced 100.4 degree temperature and chills. No treatment was received for the adverse events. The clinical outcome of the reported events was recovering at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds: Multi-Vitamin; Ther-Biotic Complete; Vitamin C

Current Illness:

ID: 1426622
Sex: M
Age:
State: MI

Vax Date: 03/18/2021
Onset Date: 03/18/2021
Rec V Date: 06/25/2021
Hospital:

Vax Type: DTAPHEPBIP
Manufacturer: GLAXOSMITHKLINE BIOLOGICALS
Vax Name: DTAP + HEPB + IPV (PEDIARIX)
Lot:
Dose Series: UNK
Vax Route:
Vax Site: LG

Lab Data:

Allergies:

Symptom List: SARS-CoV-2 antibody test, SARS-CoV-2 test negative

Symptoms: My face and hands flushed red for about 45 minutes about 30 minutes after the injection.; This is a spontaneous report from a contactable consumer, the patient. A 59-year-old male patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot number: ER2613) via unspecified route of administration on 18Mar2021 (at the age of 59-years-old) at 1000 (at the age of 59-years-old), as a single dose for COVID-19 immunisation. The patient medical history included myasthenia Gravis, Barret's, benign prostate hyperplasia (BHP), asthma, degenerative disc disease. The patient was allergic to actifed, biaxin, IVP dye(contrast), morphine, cologne/perfume. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient had received unspecified other medications within 2 weeks of vaccination. Prior to vaccination, the patient had not diagnosed with COVID-19. Since the vaccination, the patient had not tested positive for COVID-19. On 18Mar2021 at 1245, the patient experienced face and hands flushed red for about 45 minutes (also reported as about 30 minutes after the injection). No therapeutic measures were taken as a result of face and hands flushed red. The clinical outcome of the event face and hands flushed red was recovered at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1426623
Sex: F
Age:
State: TX

Vax Date: 03/15/2021
Onset Date: 03/18/2021
Rec V Date: 06/25/2021
Hospital:

Vax Type: HIBV
Manufacturer: MERCK & CO. INC.
Vax Name: HIB (PEDVAXHIB)
Lot:
Dose Series: UNK
Vax Route:
Vax Site: LG

Lab Data:

Allergies:

Symptom List: Ear pain, Hypoaesthesia

Symptoms: Full body rash breakout; Small spots with raising and clear liquid in some; This is a spontaneous report from a contactable consumer, the patient. A 34-year-old non pregnant female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: En6304), via an unspecified route of administration in the left arm on 15Mar2021 13:15 (at the age of 34-year-old) as a single dose for COVID-19 immunisation. The patient medical history was not reported. Concomitant medications included NUVARING for unknown indication. The patient has no known allergies to food, medications or other products. Prior to vaccination, it was unknown if the patient was diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. On 15Mar2021 at 20:00 the patient experienced full body rash breakout and small spots with raising and clear liquid in some. The patient did not receive any treatment for rash. The clinical outcome of the events rash and rash macular was not resolved at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds: NUVARING

Current Illness:

ID: 1426624
Sex: F
Age:
State: WV

Vax Date:
Onset Date: 02/26/2021
Rec V Date: 06/25/2021
Hospital:

Vax Type: PNC13
Manufacturer: PFIZER\WYETH
Vax Name: PNEUMO (PREVNAR13)
Lot:
Dose Series: UNK
Vax Route:
Vax Site: LG

Lab Data:

Allergies:

Symptom List: Abdominal pain upper, Dizziness, Dysgeusia

Symptoms: Migraine; vomiting; flu like symptoms; This is a spontaneous report from a contactable nurse, the patient. A 55-year-old non-pregnant female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number : EN6198, via an unspecified route of administration in the left arm on 25Feb2021 at 12:00 (at the age of 55-years old) as a single dose for COVID-19 immunisation. Medical history included connective joint arthritis, HTN, fibromyalgia. Concomitant medications include prednisone (MANUFACTURER UNKNOWN), hydrocodone (MANUFACTURER UNKNOWN), fentanyl patch (MANUFACTURER UNKNOWN), duloxetine (CYMBATLA), all for unknown indication from unknown date. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within 4 weeks prior to the vaccine. On 26Feb2021 at 00:00, the patient experienced migraine, vomiting and flu like symptoms. The clinical outcome of the migraine, vomiting and flu like symptom was recovered on unknown date in 2021. No follow-up attempts are possible needed. No further information is expected.

Other Meds: HYDROCODONE; FENTANYL PCH; CYMBALTA; PREDISONE

Current Illness:

ID: 1426625
Sex: M
Age:
State: MA

Vax Date: 03/17/2021
Onset Date: 03/19/2021
Rec V Date: 06/25/2021
Hospital:

Vax Type: RV1
Manufacturer: GLAXOSMITHKLINE BIOLOGICALS
Vax Name: ROTAVIRUS (ROTARIX)
Lot:
Dose Series: 1
Vax Route: PO
Vax Site: MO

Lab Data:

Allergies:

Symptom List: Blood pressure increased, Chest discomfort, Heart rate increased

Symptoms: swollen lymph node under left arm pit; This is a spontaneous report from a contactable patient. A 58-year-old male patient received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot no: Unknown) via unspecified route of administration in the left arm on 17Mar2021 at 1700 (at the age of 58-year-old) as a single dose for COVID-19 immunisation. The patient has no medical history and no known allergies to medications, food or other products. The patient did not have any concomitant medication. The patient previously received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Batch no: Unknown) via unspecified route of administration in the left arm on 23Feb2021 at 1700 (at the age of 58-year-old) as a single dose for COVID-19 immunisation. The patient did not have COVID-19 prior to vaccination. Since the vaccination, the patient has not been tested positive for COVID-19. On 19Mar2021, the patient experienced swollen lymph node under left arm pit. No therapeutic measures were taken for the event. The clinical outcome of the event swollen lymph node under left arm pit was not recovered at the time of this report. No follow up attempts are possible. Information about batch/lot number cannot be obtained. No further information is expected.

Other Meds:

Current Illness:

ID: 1426626
Sex: F
Age:
State: NY

Vax Date: 03/09/2021
Onset Date: 03/01/2021
Rec V Date: 06/25/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot: Eh9899
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site erythema, Injection site pruritus, Injection site swelling, Lymph node pain, Lymphadenopathy

Symptoms: swelling like a bump and pink around the injection site; swelling like a bump and pink around the injection site/swelling at the injection site; swelling like a bump and pink around the injection site; her arm was sore the first two days but then cleared up/ her injection site on her arm hurt; rash; This is a spontaneous report from a contactable consumer (patient). A 64-years-old female patient received first dose of bnt162b2 (BNT162B2, PFIZER BIONTECH COVID-19 VACCINE, solution for injection, Batch/Lot Number: ED6203, Expiration date: unknown) via an unspecified route of administration at left arm (at the age of 64-years-old) on 09Mar2021 13:45 as single dose for covid-19 immunisation. Medical history included inflammatory eye problem and ileostomy (50 years). Concomitant medications were not reported. The patient had no history of all previous immunization with the Pfizer vaccine. The patient did not receive Prior Vaccinations (within 4 weeks). On 09Mar2021, her arm was sore the first two days but then cleared up. The patient wanted to know if there were any reports of this happening a week after the shot. During the night that day her injection site on her arm hurt for a couple of days and then that completely went away. Patient wanted to know if the symptoms would get worse and the patient also had arm hurt. The patient stated that a week after her first dose, she had swelling like a bump and pink around the injection site, swelling at the injection site on 17Mar2021. On an unspecified date in Mar2021, the patient had rash. She was planning to receive the second dose on 30Mar2021. Outcome for the events vaccination site pain, Vaccination site swelling, vaccination site erythema was recovering and for the event vaccination site mass and rash was unknown. No follow-up attempts are possible. No further information is expected.

Other Meds:

Current Illness:

ID: 1426627
Sex: F
Age:
State: WA

Vax Date: 03/18/2021
Onset Date: 03/19/2021
Rec V Date: 06/25/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Unevaluable event

Symptoms: Chills 8 hours after shot; Arm soreness; This is a spontaneous report received from a contactable consumer, the patient. A 57-year-old non-pregnant female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot number: EN6208) via an unspecified route of administration in the left arm on 18Mar2021 at 15:00 (at the age of 57-years-old), as a single dose for COVID-19 immunisation. Medical history was not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications included lopreeza (MANUFACTURER UNKNOWN) 0.5 mg and melatonin (MANUFACTURER UNKNOWN) 1mg on an unknown date for unknown indication. On 19Mar2021 at 00:00, the patient experienced chills 8 hours after shot and arm soreness. The patient did not receive treatment for the reported events. The clinical outcome of the events chills and arm soreness were recovered on an unknown date. No follow-up attempts are needed. No further information is expected.

Other Meds: LOPREEZA; MELATONIN

Current Illness:

ID: 1426628
Sex: F
Age:
State: CA

Vax Date: 03/17/2021
Onset Date: 03/17/2021
Rec V Date: 06/25/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Chills, Dizziness, Injection site pain, Myalgia, Pyrexia

Symptoms: Eyes burning; Extreme sensitivity to light; Eyes hurt; Extreme shivering; Body burning in various areas; Flu like symptoms; This is a spontaneous report received from a contactable consumer. A 66 years old female patient received second dose of BNT162B2 (PFIZER BIONTECH COVID 19 MRNA VACCINE; Lot number: UNKNOWN), via unspecified route of administration, administered left arm, on 17Mar2021(at age of 66 years old) at 10:30 as a single dose for COVID 19 immunisation. The patient was allergic to drugs nitrofurantoin, pseudoephedrine and iodine and had high blood pressure. The patient previously received first dose of BNT162B2 (PFIZER BIONTECH COVID 19 MRNA VACCINE; Lot number: UNKNOWN), via unspecified route of administration on unknown anatomical location, on 24Feb2021 at 10:15am (at age of 66 years old) as a single dose for COVID 19 immunisation. Prior to vaccination, the patient was not diagnosed with COVID 19. The patient concomitant medications included Atenolol (MANUFACTURER UNKNOWN), KLONOPIN and Loratidine (MANUFACTURER UNKNOWN) from unknown dates for unknown indication. On 17Mar2021 at 12:00, the patient experienced eyes burning, extreme sensitivity to light, eyes hurt (cant turn them without pain), headache, extreme shivering for two hours or so, about 12 hours after vaccine, body burning in various areas (not all area) flu like symptoms and eyes were still hurting at the time of report. The clinical outcome of the event eyes burning, photosensitivity, eyes pain, headache, chills, extreme feeling hot of and influenza like symptoms was not recovered. No follow up attempts are possible; information about lot number cannot be obtained.

Other Meds: LORATIDINE; KLONOPIN; ATENOLOL

Current Illness:

ID: 1426629
Sex: F
Age:
State: TX

Vax Date: 03/18/2021
Onset Date: 03/19/2021
Rec V Date: 06/25/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011L20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site pain, Pain

Symptoms: Swollen lower lips, feeling a sensation of numbness and burn.; feeling a sensation of numbness; feeling a sensation of burn; This is a spontaneous report from a contactable consumer, the patient. A 27-year-old non-pregnant female patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EP6955), via an unspecified route of administration on 18Mar2021 at 13:30 in left arm for COVID-19 immunisation. Medical history of the patient included chronic pelvic pain and endometriosis. Concomitant medications were not reported. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EN6198), via an unspecified route of administration on 25Feb2021 at 11:00 in left arm for COVID-19 immunisation. The patient had no allergies to medication, food or other products. The patient did not receive any other vaccine within 4 weeks of receiving COVID-19 vaccine. The patient did not have COVID-19 test prior to vaccination. The patient was not tested positive for COVID-19 since having the vaccination. The patient experienced swollen lower lips, feeling of a sensation of numbness and burn on 19Mar2021. Therapeutic measures taken as a result of events included unknown medication for allergies prior to vaccination. The clinical outcome of swollen lower lips, feeling a sensation of numbness and burn was not recovered. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1426630
Sex: F
Age:
State: CO

Vax Date: 03/16/2021
Onset Date: 03/17/2021
Rec V Date: 06/25/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site pain, Menorrhagia

Symptoms: Injection site pain; headache; muscle pain; chills; joint pain; nausea; feeling unwell; sore throat; This is a spontaneous report from a contactable consumer, the patient. A 52-year-old non-pregnant female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EN6204) via unspecified route of administration in right arm on 16Mar2021 at 09:45 (at the age of 52-years-old), as a single dose for COVID-19 immunisation. Medical history included high blood pressure, obesity and heart palpitations. Prior to vaccination, the patient was not diagnosed with COVID-19. The concomitant medication included irbesartan (MANUFACTURER UNKNOWN), hydrochlorothiazide (MANUFACTURER UNKNOWN) and acetylsalicylic acid (ASPIRIN), from unspecified dates for unknown indications. The patient had no known allergies. The patient experienced vaccination site pain, headache, muscle pain, chills, joint pain, nausea, feeling unwell and sore throat on 17Mar2021 at 09:00. Post vaccination, the patient underwent Nasal Swab test for COVID-19 on 19Mar2021 and the result was pending. It was unknown if the patient received any treatment for vaccination site pain, headache, muscle pain, chills, joint pain, nausea, feeling unwell and sore throat. The adverse events resulted in Doctor or other healthcare professional office/clinic visit. The clinical outcome of vaccination site pain, headache, muscle pain, chills, joint pain, nausea, feeling unwell and sore throat was recovering. No follow-up attempts are needed. No further information is expected.

Other Meds: BAYER ASPIRIN; HYDROCHLOROTHIAZIDE; IRBESARTAN

Current Illness:

ID: 1426631
Sex: F
Age:
State: MA

Vax Date: 03/14/2021
Onset Date: 03/15/2021
Rec V Date: 06/25/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025J20A
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Arthralgia, Chills, Headache, Mobility decreased, Myalgia

Symptoms: eyes red; itchy eyes; watery eyes; This is a spontaneous report from a contactable consumer. A 36 year old female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; lot number: Unknown) via unspecified route of administration in the left arm on 14Mar2021 at 13:30 (at the age of 36 years) as a single first dose for Covid-19 immunisation. The patient's concomitant medications included zzzquil (MANUFACTURER UNKNOWN), junel (MANUFACTURER UNKNOWN), restasis (MANUFACTURER UNKNOWN) and fluoxetine (MANUFACTURER UNKNOWN). Allergies to medications, food, or other products was reported as gluten, liquid tylenol. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient was not diagnosed with COVID-19 prior to vaccination. On 15Mar2021 at 06:30AM, the patient experienced events eyes were red and itchy when she woke up the next morning. They were then red, itchy, and watery. The clinical outcome for events red eyes, itchy eyes and watery eyes were not recovered at the time of reporting. The patient underwent nasal swab, PCR test for COVID 19 virus on 18Mar2021, post vaccination and tested negative for the same. The patient received treatment for red, itchy and watery eyes as prednisone (MANUFACTURER UNKNOWN), Benadryl (MANUFACTURER UNKNOWN), CLARITIN, zatidar (MANUFACTURER UNKNOWN) and the adverse events resulted in doctor or other healthcare professional office/clinic visit. Information about lot/batch number cannot be obtained. No further information is expected.

Other Meds: JUNEL; RESTASIS; Zzquil; Fluoxitine

Current Illness:

ID: 1426632
Sex: F
Age:
State: MN

Vax Date: 03/06/2021
Onset Date: 03/07/2021
Rec V Date: 06/25/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Nausea, Pain in extremity, Pyrexia

Symptoms: Headache (lasted one week; not normal for patient to have headaches); fever (100.5 degrees starting 24 hours after, lowered to 99.5 degrees by 48 hours after, and remained at 99.3-ish (average) for a week); fatigue; arm soreness; This is a spontaneous report received from a contactable consumer, the patient. A 33-years-old non-pregnant female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: UNKNOWN) via an unspecified route of administration in left arm on 06Mar2021 at 15:30 (at the age of 33-years-old), as a single dose for COVID-19 immunisation. Medical history was not provided. Concomitant medications included etonogestrel/ethinyl estradiol (NUVARING), cetirizine (MANUFACTURER UNKNOWN), calcium citrate(CITRACAL), multivitamin (MANUFACTURER UNKNOWN), fiber (MANUFACTURER UNKNOWN) all from unknown dates for unknown indication. Allergies to medications, food, or other products was reported with antibiotic ointment, seasonal allergies. Prior to the vaccination, it was unknown if the patient was diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. On 07Mar2021 the patient experienced headache, fever (100.5 degrees starting 24 hours after, lowered to 99.5 degrees by 48 hours after, and remained at 99.3-ish (average) for a week), fatigue and arm soreness. The patient did not receive any treatment for events. The clinical outcome of headache, fever, fatigue and arm soreness was recovered. No follow-up attempts are needed; information about lot/batch number is requested.

Other Meds: Citracal; NUVARING; CETIRIZINE

Current Illness:

ID: 1426633
Sex: M
Age:
State: NC

Vax Date:
Onset Date: 03/12/2021
Rec V Date: 06/25/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: UNK
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Chills, Fatigue, Headache, Myalgia

Symptoms: I am suffering from extreme pain in all of my joints; I am suffering from extreme pain in muscles also; I am suffering from severe exhaustion; I am suffering from headaches; I am suffering from nausea; This is a spontaneous report received from a contactable consumer, the patient. A 64-years-old male patient received his unknown dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: UNKNOWN] via an unspecified route of administration on an unspecified date, at the age of 64 years as a single dose, for COVID-19 immunisation. Medical history included chronic obstructive pulmonary disease, hypertension and gastroesophageal reflux disease. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested positive for COVID-19. Concomitant medications included gabapentin (MANUFACTURER UNKNOWN), valsartan (MANUFACTURER UNKNOWN), hydrocortisone (MANUFACTURER UNKNOWN) and oxycodone (MANUFACTURER UNKNOWN). The patient suffered from extreme pain in all of my joints (joint pain) and muscles (muscle pain). The patient also suffered from severe exhaustion (exhaustion), headaches and nausea on 12Mar2021 at 12:00. The patient cannot do any day to day activities. The patient did not receive any treatment for events. The clinical outcome of events joint pain, muscle pain, exhaustion, headache and nausea were not recovered at the time of this report. No follow-up attempts are possible; information about lot/batch number cannot be obtained.

Other Meds: GABAPENTIN; HYDROCORTISONE; OXYCODONE; VALSARTAN

Current Illness:

ID: 1426634
Sex: F
Age:
State: NY

Vax Date: 03/18/2021
Onset Date: 03/19/2021
Rec V Date: 06/25/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Headache, Heart rate increased, Injection site erythema, Injection site pain, Injection site swelling

Symptoms: Chills,; body aches; 99.3 fever; This is a spontaneous report from a contactable consumer, the patient. A 68-year-old non-pregnant female patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE BIONTECH, Lot number: EL3247) via an unspecified route of administration in the left arm on 18Mar2021 at 10:00 (at the age of 68-years-old) as a single dose for COVID-19 immunisation. Medical history included ulcers. Concomitant medications included doxycycline (MANUFACTURER UNKNOWN), aleve (MANUFACTURER UNKNOWN) and dexilant (MANUFACTURER UNKNOWN) for unknown indications. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EL3247) via an unspecified route of administration in the left arm on 24Feb2021 at 13:30 as a single dose for COVID-19 immunisation. The patient did not have any allergies to medications, food or other products. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not tested for COVID-19. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient underwent lab tests which included body temperature on 19Mar2021 and the result was 99.3 (unspecified units). The patient experienced chills, body aches and 99.3 fever on 19Mar2021 at 12:00. The patient did not receive any treatment for the adverse events. The clinical outcome of chills, body aches and fever were resolving. No follow-up attempts are needed. No further information is expected.

Other Meds: DOXYCYCLINE; DEXILANT; ALEVE

Current Illness:

ID: 1426635
Sex: F
Age:
State: GA

Vax Date: 03/03/2021
Onset Date: 03/03/2021
Rec V Date: 06/25/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Nausea

Symptoms: Lethargy; nausea; sore arm; joint pain; This is a spontaneous report from a contactable consumer, the patient. A 73-years-old non-pregnant female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot number: Unknown) via unspecified route of administration on 03Mar2021(at the age of 73-years-old) at 11:00 as a single dose for COVID-19 immunisation. Medical history included high blood pressure, asthmatic allergies and known allergies to sulfa, penicillin, molds, pollen, nuts. Concomitant medications included amlodipine (MANUFACTURER UNKNOWN), levocetirizine (MANUFACTURER UNKNOWN), levothyroxine (MANUFACTURER UNKNOWN), losartan (MANUFACTURER UNKNOWN) for unknown indication from unknown date. The patient did not receive any other vaccines within 4 weeks prior to the COVID-19 vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. The patient had not tested for COVID-19 since the vaccination. The patient experienced joint pain, lethargy, nausea, sore arm on 03Mar2021. The patient did not receive treatment for reported adverse events. The clinical outcome of the events joint pain, lethargy, nausea and sore arm was recovered on an unknown date in Mar2021. No further information is expected. Information about lot/batch number cannot be obtained.

Other Meds: LOSARTIN; LEVOCETIRIZINE; AMLODIPINE; LEVOTHYROXINE

Current Illness:

ID: 1426636
Sex: F
Age:
State: WA

Vax Date:
Onset Date:
Rec V Date: 06/25/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: UNK
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site pain

Symptoms: face is burning/ if her cheeks are on fire; was aching all over/body aches; whole face was itching/her arm was itching; her arm has never stopped hurting/arm is killing in her/sore arm; headache; nausea; extreme fatigue; had a little fever; took benadryl because she thought it was an allergic reaction; This is a spontaneous report received from a contactable consumer or other non-health care professional. A female patient of an unspecified age received first dose of bnt162b2 (BNT162B2, PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Batch/Lot number was not reported) via an unspecified route of administration on an unspecified date as 1 st dose, single for COVID-19 immunization. The patient medical history and concomitant medications were not reported. The reporter had her first dose of the vaccine. The patient arm was killing in her, yesterday she had nausea, extreme fatigue, body aches, was aching all over and had a little fever and all of that. The caller took benadryl because she thought it was an allergic reaction and her arm was itching, face was itching and burning, she took a Benadryl, allertec and applied a cold compress to her face, face was on fire, arm pain was an 8/10 so she has been taking Tylenol. Since then, she wanted to know if this was an allergic reaction. The caller felt like it had calmed down since she took the benadryl and allertec. Patient had a headache, her arm had never stopped hurting and sore arm the first two days. The patient thought the benadryl was a trigger to this. She said she took Benadryl, and Alertex to treat the symptoms. She wanted to know if having these side effects 2 weeks after the 1st dose was normal and if these side effects have been reported before. The outcome of events was unknown. Information about lot/batch number requested.

Other Meds:

Current Illness:

ID: 1426637
Sex: M
Age:
State: DE

Vax Date: 03/19/2021
Onset Date: 03/19/2021
Rec V Date: 06/25/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site induration, Injection site pruritus, Injection site swelling, Injection site warmth

Symptoms: Lightheaded; Tiredness; Nausea; This is a spontaneous report from a contactable consumer, the patient. A 55-years-old male patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: UNKNOWN) via unspecified route in left arm on 19Mar2021 at 15:00 (at the age of 55-years-old) as a single dose for COVID-19 immunisation. Medical history included heart failure, hypertension, afib (atrial fibrillation) and Depakote allergy. Past drug history included Depakote from an unspecified date. Concomitant medications included lisinopril (MANUFACTURER UNKNOWN), MOBIC, furosemide (MANUFACTURER UNKNOWN), aspirin (MANUFACTURER UNKNOWN) and NORVAS taken within two weeks of vaccination for unknown indication. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested positive for COVID-19. It was reported that the patient did not received any other vaccines within 4 weeks prior to the COVID vaccine. On 19Mar2021 at 15:30, the patient experienced tiredness, lightheaded and nausea. No treatment was received for the events. The clinical outcome of tiredness, lightheaded and nausea was recovering. Information about lot number cannot be obtained. No further information is expected.

Other Meds: MOBIC; LISINOPRIL; NORVAS; Aspirin; FUROSEMIDE

Current Illness:

ID: 1426638
Sex: F
Age:
State: IN

Vax Date: 03/17/2021
Onset Date: 03/18/2021
Rec V Date: 06/25/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011j20a
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Chills, Dizziness, Nausea, Pain, Tachycardia

Symptoms: Vomiting; Headache; temperature; major fatigue; Chiills; body aches; This is a spontaneous report from a contactable consumer, the patient. A 48-year-old non pregnant female patient received second dose of BNT162b2(PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: unknown), via an unspecified route of administration in the right arm on 17Mar2021 at 15.00 (at the age of 48-year-old) as a single dose for COVID-19 immunisation. Medical history included sulfate allergy. Patient was taking concomitant medication however drug was unspecified . The patient previously received first dose of BNT162b2(PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: unknown), via an unspecified route of administration on an unspecified date. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient had been tested for COVID-19 nasal swab test on 22Jan2021 which resulted negative. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 18Mar2021 at 07:00, the patient experienced vomiting, headache, temperature, body aches, chills and major fatigue. The patient took Tylenol as therapeutic measure for the events. The clinical outcome of vomiting, headache, temperature, body aches, chills and major fatigue were recovering. Information about batch number cannot be obtained. No further information is expected.

Other Meds:

Current Illness:

ID: 1426639
Sex: F
Age:
State: PA

Vax Date: 03/04/2021
Onset Date: 03/01/2021
Rec V Date: 06/25/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 039K20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Tremor

Symptoms: rash from my left jaw to my groin that completely covered my torso front and back; Entire torso front and back tomy thighs turned completely red; This is a spontaneous report from a contactable nurse, the patient. A 51-year-old female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EN6206) via an unspecified route of administration in the right arm on 04Mar2021 at 18:45hrs as a single dose for COVID-19 immunisation. Relevant medical history included asthma, ocular and skin rosacea. Concomitant medications included fexofenadine(ALLEGRA) taken for an unknown indication, albuterol inhaler(MANUFACTURER UNKNOWN) taken for asthma and multi-vitamin taken for an unknown indication. The patient had history of allergies to codeine, sulfa, z pak and vicodin allergy. Prior to vaccination, the patient was not diagnosed with COVID-19. The patient underwent a nasal swab test (PCR test) on 10Mar2021 for COVID-19 and the result found to be positive. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccine. The patient experienced a rash two days after the vaccination on 06Mar2021. The patient reported that the rash extended from the left jaw to the groin region that completely covered his torso front and back. On an unspecified date in Mar2021, the patient reported that the rash faded away and the entire torso front and back to his thighs turned completely red as if the patient had a sunburn. The patient did not have any pain or itching. The adverse events resulted in a doctors or other healthcare professional visit. Therapeutic measures included intake of BENADRYL. The clinical outcome for the event rash was resolved on 08Mar2021 and the clinical outcome for the event entire torso front and back to thighs turned completely red was resolved on an unknown date in Mar2021. No follow-up attempts are needed. No further information is expected.

Other Meds: ALLEGRA; Albuterol

Current Illness:

ID: 1426640
Sex: F
Age:
State: WI

Vax Date: 03/17/2021
Onset Date: 03/17/2021
Rec V Date: 06/25/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Erythema, Pruritus

Symptoms: Dizziness; Nausea; Blurred vision; Elevated blood pressure; This is a spontaneous report received from a contactable consumer, the patient. A 65-year-old non pregnant female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: ER2613) via unspecified route of administration on left arm on 17Mar2021 at 13 hours (at the age of 65-year-old) as a single dose for COVID-19 immunisation. Medical history included gluten and alcohol allergy. Past drug history included allergy to codeine. Concomitant medications were not reported. The patient had no symptoms associated with COVID-19. Since the vaccination, the patient had not been tested positive for COVID-19. On 17Mar2021 at 13:15 hours the patient experienced dizziness, nausea, blurred vision and elevated blood pressure. The adverse events resulted in emergency room/department or urgent care visit. No therapeutic measures were taken for the events. The clinical outcome of events dizziness, nausea, blurred vision, elevated blood pressure was recovered on an unspecified date. No follow-up attempts are needed. No further information is expected

Other Meds:

Current Illness:

ID: 1426641
Sex: F
Age:
State: AL

Vax Date: 03/16/2021
Onset Date: 03/16/2021
Rec V Date: 06/25/2021
Hospital:

Vax Type: UNK
Manufacturer: UNKNOWN MANUFACTURER
Vax Name: VACCINE NOT SPECIFIED (NO BRAND NAME)
Lot:
Dose Series: UNK
Vax Route: SYR
Vax Site: UN

Lab Data:

Allergies:

Symptom List: Injection site erythema, Injection site induration, Injection site pruritus, Injection site swelling, Myalgia

Symptoms: Upset stomach; upset stomach and swollen and itchy; Body ache; Itchy rash; fever of 102.4 F; Extremely bad headache; This is a spontaneous report received from a contactable patient. A 52-year-old adult non pregnant female patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: UNKNOWN) via unspecified route of administration on 16Mar2021 at 13:15 (at the age of 52 years) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested positive for COVID-19. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. On 16Mar2021 at 16:00, the patient experienced rash, fever of 102.4 F, upset stomach and swollen and itchy, extremely bad headache and body ache. The patient underwent lab tests and procedures, which included body temperature measurement on 16Mar2021 at 16:00 and result was 102.4 F. No therapeutic measures were taken in response to the events. The clinical outcome of events itchy rash, fever, upset stomach, swelling extremely bad headache and body ache was recovered with sequalae. No follow-up attempts are possible; information about lot/batch number cannot be obtained

Other Meds:

Current Illness:

ID: 1426642
Sex: F
Age:
State: AZ

Vax Date: 03/15/2021
Onset Date: 03/15/2021
Rec V Date: 06/25/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Cough, Limb discomfort, Pain, SARS-CoV-2 test positive

Symptoms: Not feeling good 4 days after shot; Dry mouth on and off since shot.; This is a spontaneous report from a contactable patient. A 60-year-old non-pregnant female patient received first dose of BNT162b2 (PFIZER BIONTECH mRNA COVID-19 vaccine; Lot number: UNKNOWN) via an unspecified route of administration in the left arm on 15Mar2021 at 17:30 hours (at the age of 60-year-old) for COVID-19 immunisation. Medical history was not reported. Concomitant medications reported as clonazepam (MANUFACTURER UNKNOWN) taken within prior two weeks of vaccination. The patient was reported to be allergic to codeine and dilladid. Prior to vaccination, the patient was not diagnosed with COVID-19. Since vaccination, the patient has not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to vaccination. On 15Mar2021 at 18:00 hours, the patient experienced dry mouth on and off and on 19Mar2021, the patient was feeling unwell. No therapeutic measures were taken by the patient for the events. The clinical outcome of event dry mouth was not recovered, while the outcome of feeling unwell was unknown at the time of report. No follow-up attempts are possible; information about lot number cannot be obtained.

Other Meds: CLONAZEPAM

Current Illness:

ID: 1426643
Sex: F
Age:
State: FL

Vax Date: 03/18/2021
Onset Date: 03/19/2021
Rec V Date: 06/25/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 039K20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Asthenia, Chills, Headache, Myalgia

Symptoms: Fatigue; Nausea; Headache; High fever; This is a spontaneous report received from a contactable patient. A 64-year-old adult non pregnant female patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, lot number: unknown) via unspecified route of administration on left arm on 18Mar2021 at 0100 (at the age of 64 year) as a single dose for COVID-19 immunisation. Medical history and concomitant medication were not provided. The patient previously received treatment with codeine (MANUFACTURER UNKNOWN) from an unspecified date and experienced drug allergy. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested positive for COVID-19. On the next day of vaccination, on 19Mar2021, the patient experienced fatigue, nausea, headache and high fever. The patient received treatment with paracetamol (TYLENOL) in response to the events. The clinical outcome of the events fatigue, nausea, headache and high fever was not recovered at the time of this report. No follow-up attempts are possible; information about lot/batch number cannot be obtained

Other Meds:

Current Illness:

ID: 1426644
Sex: M
Age:
State: WA

Vax Date: 02/01/2021
Onset Date: 03/07/2021
Rec V Date: 06/25/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011J20A
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site erythema, Injection site pain, Injection site swelling

Symptoms: This is a spontaneous report from a contactable consumer, the patient. A 47-years-old Caucasian male patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot number: EN6198) via an unspecified route of administration in the left arm in Feb2021 (at the age of 46-years-old) as a single dose for COVID-19 immunization. The patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot number: EN6208) via an unspecified route of administration in the left arm on 14Mar2021 (at the age of 47-years-old) as a single dose for COVID-19 immunization. The patient medical history included Benign prostatic hyperplasia (BPH); Eagle's Syndrome, bilateral styloidectomy; and previous paraesophageal hiatal hernia repair. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient was not diagnosed with COVID-19 since the vaccination. The patient had not tested for COVID-19. No allergies to medications, food, or other products. Concomitant medication included tamsulosin 0.4mg (MANUFACTURER UNKNOWN). On 07Mar2021 08:00, the patient experienced arthritic-like pain in multiple joints beginning in the days preceding the second dose of the vaccine and becoming more severe following the second dose. The pain was specifically in hands, feet, ankles and knees, but originating in the hands bilaterally. This might be coincidental timing, but could possibly be related to vaccine. The adverse event led to doctor or other healthcare professional clinic visit. The patients blood tests showed C-reactive protein at 14 mg/L, negative ANA and negative RF. The patient was prescribed diclofenac. The clinical outcome of arthritic-like pain was not recovered. No follow-up attempts are needed. No further information is expected.

Other Meds: TAMSULOSIN

Current Illness:

ID: 1426645
Sex: F
Age:
State: OK

Vax Date: 03/16/2021
Onset Date: 03/16/2021
Rec V Date: 06/25/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot: EK9231
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Chills, Feeling cold, Feeling hot, Myalgia, Pain

Symptoms: Exhausted; stomach cramps; gassy; diarrhea; headaches; sweaty; sore arm; This is a spontaneous report from a contactable consumer, the patient. A 62-year-old non-pregnant female patient received her second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: unknown), via an unspecified route of administration in the left arm on 16Mar2021 at 1345 as a single dose for COVID-19 immunisation. Concomitant medications taken within two weeks of vaccination included gabapentin (MANUFACTURER UNKNOWN), rosuvastatin calcium (MANUFACTURER unknown) and sertraline (MANUFACTURER UNKNOWN) and hydroc ( MANUFACTURER UNKNOWN ) all since an unknown date. The patient previously received her first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; lot number: unknown), via an unspecified route of administration in the left arm on 02Feb2021 at 1245, as a single dose for COVID-19 immunisation. Prior to vaccination, the patient was not diagnosed with COVID-19 and also did not receive any other vaccine within four weeks of vaccination. The patient had undergone nasal swab, COVID-19 quick test on 07Dec2020 and tested negative. Since the vaccination, patient had not tested for COVID-19. On 16Mar2021, the patient experienced exhausted, stomach cramps, gassy, diarrhea, headaches, sweaty and sore arm. The clinical outcome of all events was not recovered. No follow-up attempts are possible; information about lot/batch number cannot be obtained.

Other Meds: GABAPENTIN; SERTRALINE; Rosuvastatin calcium .

Current Illness:

ID: 1426646
Sex: F
Age:
State: ID

Vax Date: 03/19/2021
Onset Date: 03/19/2021
Rec V Date: 06/25/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Pain in extremity

Symptoms: Stomach cramp; sweating; nausea; dizzy weak; This is a spontaneous report received from a contactable consumer, the patient. A 57-year-old non-pregnant female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot number: UNKNOWN) via an unspecified route of administration in the left arm on 19Mar2021 at 13:00 (at the age of 57-year-old) as a single dose for COVID-19 immunisation. The patient did not had any medical history and not had allergies to medications, food, or other products. The patient's concomitant medications were not reported. She did not received any other vaccines within 4 weeks prior to COVID-19 vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 19Mar2021 at 13:45, the patient experienced stomach cramp, sweating, nausea and dizzy weak. Therapeutic measures were taken as the result of events was unknown. The clinical outcome of the events stomach cramp, sweating, nausea and dizzy weak was unknown at the time of this report. Information about lot/batch number cannot be obtained. No further information is expected.

Other Meds:

Current Illness:

ID: 1426647
Sex: M
Age:
State: TX

Vax Date: 02/27/2021
Onset Date: 03/10/2021
Rec V Date: 06/25/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot:
Dose Series: 2
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Abdominal pain upper, Abnormal behaviour, Adverse reaction, Anger, Asthma

Symptoms: Both arms broke out with a rash of little fine bumps; This is a spontaneous report received from a contactable consumer, the patient. A 64-year-old male patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: UNKNOWN), via an unspecified route of administration in the left arm on 27Feb2021 at 02:15 (at the age of 64-years-old) as a single dose for COVID-19 immunisation. Medical history included diabetes. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. Concomitant medications were not reported. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. On 10Mar2021 at 00:00, the patient's both arms broke out with a rash of little fine bumps. The patient did not receive any treatment for the event both arms broke out with a rash of little fine bumps. The clinical outcome of the event both arms broke out with a rash of fine bumps was not resolved at the time of the report. Information about lot/batch number cannot be obtained. No further information is expected.

Other Meds:

Current Illness: Diabetes

ID: 1426648
Sex: F
Age:
State: NC

Vax Date: 03/18/2021
Onset Date: 03/18/2021
Rec V Date: 06/25/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 039K20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Consciousness fluctuating, Crying, Dry skin, Epistaxis, Headache

Symptoms: Developed a swollen lymph node under right arm.; itchy throat; Started with itchy nose; cough; nausea; headache; Temp 99.5.; heavy chest; hard breathing; Body aches occurred overnight; This is a spontaneous report from a contactable consumer, the patient. A 40-year-old non pregnant female patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EL22613), via an unspecified route of administration in the right arm on 18Mar2021 at 10:45 (at the age of 40-years-old) as a single dose for COVID-19 immunisation. Medical history included hypothyroidism, depression/anxiety, and heart burn. Concomitant medications received within 2 weeks of vaccination included levothyroxine (MANUFACTURE UNKNOWN), fluoxetine (MANUFACTURE UNKNOWN), norgestimate and ethinyl estradiol (TRI-LO SPRINTEC) and omeprazole (OMEPRA), all for unknown indications from unknown date. The patient previously received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EL9263), via an unspecified route of administration in the right arm on 25Feb2021 at 12:00 as a single dose for COVID-19 immunisation. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccination. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not tested for COVID-19. On 18Mar2021 at 16:00, the patient experienced itchy nose and throat that developed into cough, nausea, and headache. Temp 99.5 and developed into heavy chest and hard breathing. Body aches occurred overnight and into the morning of 19Mar2021. Coughing, nausea, and body aches continued, and developed a swollen lymph node under right arm. The patient did not receive treatment for the reported adverse events. The clinical outcome of itchy nose, itchy throat, headache, temperature 99.5, heavy chest, hard breathing, swollen lymph node under right arm were recovering, and body aches, nausea, cough was not recovered. No follow up attempts are needed. No further information is expected.

Other Meds: tri-lo sprintec; FLUOXETINE; LEVOTHYROXINE; OMEPRA

Current Illness:

ID: 1426649
Sex: F
Age:
State: AZ

Vax Date: 03/09/2021
Onset Date: 03/10/2021
Rec V Date: 06/25/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Hypotonia, Lethargy, Respiratory rate decreased, Screaming, Skin warm

Symptoms: Constant headache; Severe neck pain; This is a spontaneous report from a contactable healthcare professional, the patient. A 43-year-old non-pregnant female patient received her second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EN9269), via intramuscular route in the left arm on 09Mar2021 at 12:30 (at the age of 43-years-old), as a single dose for COVID-19 immunisation. Medical history included anxiety and depression. The patient had no allergies to medications, food, or other products. Prior to vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Concomitant medication included fluoxetine (MANAFACTURER UNKNOWN) 40 mg for an unknown indication. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot number: EL9269), via intramuscular route in the left arm on 15Feb2021 at 12:00 (at the age of 43-years-old), as a single dose for COVID-19 immunisation. Since the vaccination, the patient had not been tested for COVID-19. On 10Mar2021, the patient experienced constant headache and severe neck pain that moves for over a week. The patient did not receive any treatment for the reported events. The clinical outcome of the events head ache and neck pain was not recovered. No follow-up attempts are needed. No further information is expected.

Other Meds: FLUOXETINE

Current Illness:

ID: 1426650
Sex: F
Age:
State: VA

Vax Date: 03/18/2021
Onset Date: 03/18/2021
Rec V Date: 06/25/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 026LZOA
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Vomiting

Symptoms: STINGING AND TINGLING DOWN ARM AFTER INJECTION; STINGING AND VERYSORE UPPER LEFT ARM; This is a spontaneous report from a contactable consumer, the patient. A 61-year-old female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number -unknown), in the left arm via an unspecified route of administration on 18Mar2021 as single dose (at the age of 61-years-old) for COVID-19 immunisation. Medical history included chronic obstructive pulmonary disease (COPD), asthma and Immune deficiency. The patient had history of drug allergy to penicillin, biaxin, bactrim, levoquin, codine, opioids and doxycycline. The concomitant medication included XOLAIR since an unspecified date. Prior to vaccination, the patient was not diagnosed with COVID-19 and since the vaccination, she was not tested positive for COVID-19. The patient had not received any other vaccines within 4 weeks prior to the COVID vaccine. On 18Mar2021, the patient experienced stinging and tingling down arm after the injection(paraesthesia) and had very sore upper left arm (pain in extremity). The clinical outcome of the events paraesthesia and pain in extremity was not resolved at the time of the report. Information about lot number cannot be obtained. No further information is expected.

Other Meds: XOLAIR

Current Illness:

ID: 1426651
Sex: F
Age:
State: MN

Vax Date: 03/18/2021
Onset Date: 03/19/2021
Rec V Date: 06/25/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 037K20A
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Headache, Limb discomfort, Nasal congestion

Symptoms: Reactivation of postherpetic neuralgia that had previously been resolved for more than one year; This is a spontaneous report from a contactable consumer, the patient. A 35-Year-old non pregnant female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; lot number: unknown), via unspecified route of administration in left arm on 18Mar2021 at 12:45 (at the age of 35-years-old) as a single dose for COVID-19 immunisation. Medical history included occipital neuralgia and post herpetic neuralgia. Concomitant medications included escitalopram (LEXAPRO) and topiramate (TOPIMAX), from an unknown date for unknown indication. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 19Mar2021, at 07:30, the patient experienced reactivation of post herpetic neuralgia that had previously been resolved for more than one year. The patient did not receive any treatment for the event. The clinical outcome of the event disease recurrence was not recovered at the time of report. No follow-up attempts are possible; information about lot/batch number cannot be obtained.

Other Meds: Topimax; LEXAPRO

Current Illness:

ID: 1426652
Sex: U
Age:
State: AZ

Vax Date: 03/16/2021
Onset Date: 03/17/2021
Rec V Date: 06/25/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Back pain, Cold sweat, Headache, Nausea, Vomiting

Symptoms: Swelling of left lymph node in armpit near injection site; Severe throbbing for 2.5 days and tender.; Severe throbbing for 2.5 days and tender.; joint pain concentrated in kneecaps; headache; This is a spontaneous report from a contactable consumer, the patient. A 64- years old patient of an unknown gender received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: ER2613), via an unspecified route of administration in the left arm on 16Mar2021 at 15:45 as a single dose for COVID-19 immunisation. Medical history included allergic to latex. Concomitant medications included aspirin (MANUFACTURER UNKNOWN), multi-B vitamin (MANUFACTURER UNKNOWN), vitamin D (MANUFACTURER UNKNOWN), and zinc (MANUFACTURER UNKNOWN) for an unknown indication from an unknown date. Prior to the vaccination, the patient was diagnosed with COVID-19. Since the vaccination, the patient had not tested for COVID-19. The patient had not received any other vaccines within four weeks, prior to the COVID-19 vaccine. On 17Mar2021 at 03:00, patient experienced swelling of left lymph node in armpit near injection site, severe throbbing for (2.5 days), tender, headache, joint pain concentrated in the kneecaps and back for 2 days. The clinical outcome for the events lymph node swollen, headache, joint pain, tenderness and throbbing pain was recovering. No follow-up attempts are needed. No further information is expected.

Other Meds: Vitamin D; ZINC; Aspirin

Current Illness:

ID: 1426653
Sex: F
Age:
State: TX

Vax Date: 03/10/2021
Onset Date: 03/10/2021
Rec V Date: 06/25/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025j20-2A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site swelling, Limb discomfort

Symptoms: redness at site; itchiness; hot raised lump; mild headache; arm soreness; This is a spontaneous report from a contactable consumer, the patient. A 30-year old female patient received first dose of BNT162b2(PFIZER-BIONTECH COVID-19 mRNA VACCINE, lot number: EN6205) via an unspecified route of administration in the left arm on 10Mar2021 at 14:30 (at the age of 30-year-old) as a single dose for COVID-19 immunisation. Medical history included chronic migraines, allergies, exercise induced asthma. The patient had allergies to all sulfa drugs, polytrim eyedrops, oranges, fire, ants, bees, wasps, hornets, cats. The patients concomitant medication included norethindrone acetate (MANUFACTURER UNKNOWN), dosage: 1mg/20mcg for unknown indication from unknown date and unknown if ongoing. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 10Mar2021 at 14: 30, day 1 (as reported) patient experienced redness at site, itchiness, hot raised lump, mild headache, arm soreness. On day 9 (as reported) patient experienced still very red, very itchy, lump is still raised and had not reduced in size or redness. no pain, but still hot. The clinical outcomes of the events redness at site, itchiness, hot raised lump, mild headache, arm soreness was not recovered. No follow-up attempts are needed. No further information is expected.

Other Meds: NORETHINDRONE ACETATE

Current Illness:

ID: 1426654
Sex: F
Age:
State: CA

Vax Date: 03/19/2021
Onset Date: 03/19/2021
Rec V Date: 06/25/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Chills, Diarrhoea, Fatigue, Feeling abnormal, Headache

Symptoms: This is a spontaneous report from a contactable consumer, the patient. A 53-year-old non-pregnant female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: unknown) via an unspecified route of administration in the right arm 19Mar2021 at 10:30 (at the age of 53-years-old) as a single dose for COVID-19 immunization. The medical history included fibromyalgia, chronic fatigue, allergies, migraines, cervical stenosis, restless legs and pain. The patient had a history of allergy to penicillin, sulfa, Keflex, adhesives, iodine contrast, cats, ropinirole and others. Concomitant medication included plaquenil (MANUFACTURER UNKNOWN), tolterodine (MANUFACTURER UNKNOWN), ASPIRIN, clonazepam (MANUFACTURER UNKNOWN) for an unknown indication. The patient did not receive any other vaccines within 4 weeks prior to the COVID-19 vaccine. Prior to vaccination patient was not diagnosed with COVID-19. The patient had not been tested positive for COVID-19 since vaccination. On 19Mar2021 at 11.15, the patient experienced some itching on right arm, but thought it was a scrape irritated by sun, the arm that was not the injection arm was still pretty red and face was fairly flushed and there was a single hive. When patient took shower, she started to feel itchy burning on scalp, ears, and nose, which was not terrible. While in the shower, her arm started to ache and felt dizzy. When she went out, the itching continues at almost 17:00. The patient was not having a bad time breathing. The patient had taken allergy medicine before the shot. The events didn't resulted in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Treatment received for the reported events were unknown. The clinical outcome of the events itching, hives, pain in arm, flushing and dizzy were not recovered. Information about lot number cannot be obtained. No further information is expected.

Other Meds: Plaquenil; CLONAZEPAM; TOLTERODINE; aspirin

Current Illness:

ID: 1426655
Sex: F
Age:
State: CA

Vax Date: 03/17/2021
Onset Date: 03/17/2021
Rec V Date: 06/25/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 037K20A
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Hot flush, Myalgia, Nausea, Tension headache

Symptoms: Swollen lymph nodes; This is a spontaneous report received from a contactable nurse, the patient. A 49-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: PF208ENG202), via an unspecified route of administration in the left arm on 17Mar2021 at 12:00 (at the age of 49-years-old) as a single dose for COVID-19 immunisation. Medical history included pre-type-2 diabetes mellitus, lupus and COVID-19. Concomitant medication included metformin (MANUFACTURER UNKNOWN) and hydrochlorothiazide (MANUFACTURER UNKNOWN); both for unknown indications, from unknown dates. The patient previously took penicillin for unknown indication and experienced an allergy. The patient did not receive any other vaccines within 4 weeks prior to the COVID-19 vaccination. Since the vaccination, the patient had not been tested for COVID-19. On 17Mar2021, the patient experienced swollen lymph nodes. The patient did not receive any treatment for the reported event. The clinical outcome of the event swollen lymph nodes was not recovered. No follow-up attempts are needed. No further information is expected.

Other Meds: METFORMIN; HYDROCHLOROTHIAZIDE

Current Illness:

Total 2021 VAERS Injuries: 636,615

Page last modified: 03 October 2021 5:28pm